www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
Arming white blood cells to fight cancer. Scientists at Tel Aviv University have discovered that the white blood cells called Eosinophils secrete powerfully destructive proteins that can kill tumors. When activated by the protein IFN-gamma, they induced an even greater immunotherapy response and a new anti-cancer pathway.
https://www.jewishpress.com/news/science-and-tech/israeli-research-white-blood-cells-related-to-allergies-asthma-may-also-destroy-cancer-cells/2019/01/22/
New biomarker helps detect high risk of cancer. Researchers from Tel Aviv University and others have found that high levels of the protein ubiquilin-4 cause cells to become prone to genome instability and more likely to develop into tumors. Once discovered, these cells can be treated with other forms of cancer therapy.
https://www.israel21c.org/israelis-find-biomarker-linking-genome-instability-cancer/
https://www.aftau.org/weblog-medicine–health?&storyid4704=2430&ncs4704=3
Successful trials of treatment for severe burns. I reported previously (see here) on the innovative NexoBrid treatment for severe burns from Israel’s MediWound. MediWound has just announced positive top line results of its pivotal U.S. Phase 3 clinical study. Dead skin was completely removed from 93% of trial patients.
http://ir.mediwound.com/news-releases/news-release-details/mediwound-announces-positive-top-line-results-its-pivotal-phase
US approval for groundbreaking inhaler. (TY Atid-EDI) The US FDA has approved the ProAir Digihaler made by Israel’s Teva. It is the first and only digital inhaler with built-in sensors that connects to a companion mobile app and provides relevant information to people with asthma and COPD.
https://www.marketwatch.com/press-release/teva-announces-fda-approval-of-first-and-only-digital-inhaler-with-built-in-sensors-proair-digihalertm-albuterol-sulfate-117-mcg-inhalation-powder-2018-12-21
The neurons that recognize a face. Researchers at Israel’s Bar Ilan University and in Paris have identified neurons in the human visual cortex that can selectively respond to faces. The discovery came while studying an epileptic patient that had micro-electrodes implanted in the vicinity of the Fusiform Face Area.
https://www.timesofisrael.com/i-see-you-in-first-israeli-french-team-finds-neurons-that-respond-to-all-faces/
http://n.neurology.org/content/92/4/197
Breakthrough cancer treatment available to Israelis. (TY I24 News) The Israeli-developed CAR-T cancer treatment is one of NIS 460 million worth of new treatments added to Israel’s 2019 Health Basket. CAR-T has over 80% success rate, even in terminal cases. The new treatments will benefit an estimated 70,000 Israelis.
https://www.youtube.com/watch?v=r7UtUXNF4_U
http://www.israelnationalnews.com/News/News.aspx/257940
https://en.globes.co.il/en/article-over-half-israels-2019-drug-basket-budget-goes-to-cancer-1001267676